- Home
- PTCT vs MIR Comparison
PTCT vs MIR Comparison
Compare PTCT & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTCT | MIR |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.7B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTCT | MIR |
|---|---|---|
| Price | $77.48 | $25.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 7 |
| Target Price | ★ $73.76 | $28.57 |
| AVG Volume (30 Days) | 2.3M | ★ 3.6M |
| Earning Date | 11-04-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 8.94 | 0.10 |
| Revenue | ★ $1,779,150,000.00 | $902,300,000.00 |
| Revenue This Year | $128.32 | $8.15 |
| Revenue Next Year | N/A | $19.02 |
| P/E Ratio | ★ $8.64 | $246.49 |
| Revenue Growth | ★ 97.54 | 7.82 |
| 52 Week Low | $35.95 | $12.00 |
| 52 Week High | $87.50 | $30.28 |
Technical Indicators
Market Signals| Indicator | PTCT | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 48.73 |
| Support Level | $73.03 | $24.50 |
| Resistance Level | $79.03 | $25.75 |
| Average True Range (ATR) | 3.38 | 1.18 |
| MACD | -0.70 | -0.01 |
| Stochastic Oscillator | 29.37 | 67.19 |
Price Performance
Historical ComparisonAbout PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.